Mayor Ras Baraka said it's part of an effort that started with new housing and is now trying to solve the root of the problem ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Excessive sugar intake can increase pancreatic cancer risk, as shown by a case of a Chinese architect diagnosed with stage 2 ...

Pancreatic cancer survivor Pranathi Perati talks about the importance of clinical trials for patients facing this tough ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in ...

On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...

Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to ...